The Patent Finder

Terms ending in 2032

Genmab A/S

Every in-force patent on Genmab A/S's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,322,035Recombinant IGG4 Monovalent Antibodies
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,212,230Bispecific Antibodies and Methods for Production Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,046,771Monoclonal Antibodies Against HER2
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,793,640Monoclonal Antibodies Against HER2 Epitope
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,578,141Bispecific Antibodies Against HER2 and CD3
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,862,769Monoclonal Antibodies Against HER2
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,512,140Monoclonal Antibodies Against C-Met
In force
 · Medium confidence
Genmab A/SIn forceMedium confidence
US 11,091,553Monoclonal Antibodies Against HER2
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,540,433Human Antibodies and Antibody-Drug Conjugates Against CD74
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,795,214Modulation of Complement-Dependent Cytotoxicity Through Modifications of the C-Terminus of Antibody Heavy Chains
In force
 · High confidence
Genmab A/SIn forceHigh confidence
2 more term ends in 2032 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited